Patenting antibodies at the EPO

Presented by

Hazel Ford (Mathys & Squire), Martin MacLean (Mathys & Squire), Peter Scott (WIPR)

About this talk

European Patent Office (EPO) practice in relation to antibody inventions has developed over the years to take account of progress in the law and advances in technology. The EPO’s approach to patenting antibodies has now been formalised for the first time in the latest edition of the EPO’s Guidelines for Examination (March 2021). In this webinar, Martin MacLean and Hazel Ford of Mathys & Squire will discuss the key issues that are likely to arise when dealing with antibody cases at the EPO, and will review the factors that the EPO will take into account when assessing patentability and when considering what is an appropriate breadth of patent in this technical area.

Related topics:

About this channel

World Intellectual Property Review Insights
Upcoming talks (1)
On-demand talks (52)
Subscribers (7444)
Content for the home of World IP Review and Life Sciences IP Review